Psychology Research class

Instructions for summarizing a chapter or article.
Assignment:

1. Write down each chapter title of the book. This will serve as the topic for each segment of the book you are summarizing.

2. Below each chapter title that you have listed, write down the main ideas corresponding to each chapter anything in bold or script. Try to be as simple and direct as possible. Avoid lengthy and complex sentences. Keep straight to the point. This will help you remove unnecessary words that are better left out.

3. The chapter titles and their corresponding main ideas that you have just listed down will serve as the outline of your book summary. Try to pick things up from there and expand your sentences by elaborating the ideas.

• DO NOT write whether the book is poorly written or excellently discusses the ideas. Remember, you are simply writing a summary and NOT a book review.

• DO NOT write down irrelevant ideas. They only make your book summary a mess.

• DO NOT make-up ideas that are not included in the book. Be as honest as possible. Write only what the author has said and not what was not stated.

•   Read the entire text, noting the key points and main ideas.
•   Summarize in your own words what the single main idea of the essay is.
•   Paraphrase important supporting points that come up in the essay.
•   Consider any words, phrases, or brief passages that you believe should be quoted directly.
The Title of the Article is Alzheimer’s a test for the disease raises thorny ethical issues, Would you want to Know?.

Alzheimerts
A test for the disease raises thorny ethical issues
Wo You Want to Know? Bypeter Jaret
learningth u’re likely to develop Alzheimer’s could cause more harm than good.
Toknowor to know Experts say that developing
a test for Al mer’s allows for the possibility of rnore
effective treat nt. “The main problem with treating
Alzheimer’s d
probablygiven
ease today is that the medicines are
late to do much good,” says Howard
Federoff, M.D. of neurology at Georgetown
University M
hen researchers recently announced a promising new blood test for
Alzheimer’s disease-one that could be as simple to perform as a standard
cholesterol test-reactions were rnixed. while some experts
news, others worried that, until effective treatments are available,
ical Center, who was part of the team
the test. “Our research reports a bio-
I allow us to select pafients who have
very early di , and we can determine if medicines
are more effect when given eariier.”
There’s al y good evidence that simple lifestyle
changes can he slow the likelihood of developing dementia,
says J Karlawish, M.D., professor of medicine
at the Uni ity of Pennsylvania, who was not
involved in
who learn that they tested positive judge their
memories more critically and perform worse on
memory tests than those who are not told.
And there’s gnother worry. Like almost all
tests, the new blood test isn’t perfect. The 90
percent accuracy rate means that some people
would be told they will likely develop
Alzheimer’s over the next several years when, in
fact, they won’t, “That would mean someone’s life was
turned upside down for nothing” says Klugman.
A changing landscape The flurry of headlines that
greeted the announcement of a new blood test gave
the impression that it was just around the corner. It
isn’t. The preliminary results must first be confirmed
by other independent research teams. Even then, says
Mark Mapstone, an associate professor of neurology at
the University ofRochester Mediial Center and another
member of the team that developed the blood test, it
“would likelybe used in high-risk individuals”-people
with a family history of Alzheimer’s, for instance.
By that time, researchers
say, they are likely to know
much more about Alzheimer’s
disease and even how
to slow its progress. The
blood test already offers important
clues, according to
Federoff. The changes that
have been observed in the
blood are believed to result
from the breakdown of brain
cell membranes in people destined to develop the disease.
The researchers are continuing to look at other
molecules in the blood that would give a more detaiied
glimpse into what goes wrong in people at risk.
In other research, scientists are recruitingvolunteers
for a program called the A4 Study, which will test an
experimental drug that could slow cognitive decline
in people who are at risk of memory loss because of
Aizheimer’s. Researchers at Harvard vtedical School
recently announced that a naturally occurring protein
may protect against the development of Alzheimer’s
disease and age-related dementia-and these findings
could open up a new area of treatment.
heralded th
that develo
md.rker that w
physicalactivi
help preserve
depressed and
living with this
mension of your
People who
burden offeeli
The stress of I
Alzheimer’s cou
Indeed, a recent
a genotype that
itive function,” he says. People who
learn that they at high risk of developingAlzheimer’s
may be more ivated to make healthy changes.
In addition, rly detection would allow people to
make inforrned ecisions about their care before the
symptoms of A
both the Alzhei
imer’s get in lhe way-one reason
‘s Association and the Alzheimer’s
Foundation of rica support early diagnosis.
Living with a of doom But there are worries.
‘Apositive lesul a test like this could be devastating,”
says Craig a bioethicist who chairs the Department
of Health iences at DePaul University. “It could
change people’s tlook on life, making them anxious,
oping the test. ‘A heart-heaithy diet,
nd social and cognitive stimulation can
thdrawn. Suddenly you find yourself
nse of doom that can affect everv dife.”
positive might also suffer the added
tigmatized or ashamed, experts warn.
rning that you are likely to develop
even worsen the symptoms of forgetfulness and confusion.
“What a simple momentary lapse of memory before now
‘As long as there is no effective treatment, there’s a reai question about
whether to offer a test,” says Klugman. “Bul once we have ways to slow or
becomes a terri ing symptom of this dread disease,” says Klugman. stop the disease, there are many fewer reasons against testing.” D
y looked at the effect oftelling people that they carry
ts them at high risk of developingAlzheimer’s. Those Peter Jaret writes on health and medical issues for national publications.